{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:15:23Z","timestamp":1771168523946,"version":"3.50.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejogrb.2025.02.038","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:56:42Z","timestamp":1740185802000},"page":"54-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Diagnostic accuracy of available methylation assays in advanced cervical intraepithelial neoplasia from high-risk HPV-positive women: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"308","author":[{"given":"Xiang","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.02.038_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/GRF.0b013e31804a8285","article-title":"Cervical cancer screening in the 21st century: is it time to retire the PAP smear?","volume":"50","author":"Wright","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijc.30534","article-title":"Performance of a new HPV and biomarker assay in the management of hrHPV positive women: subanalysis of the ongoing multicenter TRACE clinical trial (n > 6,000) to evaluate POU4F3 methylation as a potential biomarker of cervical precancer and cancer","volume":"140","author":"Kocsis","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0035","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/jjco\/hyab109","article-title":"Emerging technologies for cervical cancer screening","volume":"51","author":"Hamashima","year":"2021","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/1471-0528.16395","article-title":"The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review","volume":"128","author":"Kremer","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0045","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s41416-019-0593-4","article-title":"Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia (CIN2+): a systematic review and meta-analysis","volume":"121","author":"Kelly","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred Reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-127-5-199709010-00008","article-title":"Formulating questions and locating primary studies for inclusion in systematic reviews","volume":"127","author":"Counsell","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0065","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1177\/0962280216669182","article-title":"ANOVA model for network meta-analysis of diagnostic test accuracy data","volume":"27","author":"Nyaga","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0070","article-title":"Network meta-analysis: application and practice using R software","volume":"41","author":"Shim","year":"2019","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0080","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1111\/aos.13568","article-title":"Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension: a systematic review and network meta-analysis","volume":"96","author":"Li","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0085","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ijc.34050","article-title":"DNA methylation testing with S5 for triage of high-risk HPV positive women","volume":"151","author":"Adcock","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0095","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13148-020-00849-x","article-title":"Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16\/18 and cytology","volume":"12","author":"Gu","year":"2020","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13148-019-0743-9","article-title":"Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16\/18 genotyping","volume":"11","author":"Hernandez-Lopez","year":"2019","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0105","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/ijc.30008","article-title":"Validation of a DNA methylation HPV triage classifier in a screening sample","volume":"138","author":"Lorincz","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/ijc.33314","article-title":"Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country","volume":"148","author":"Ram\u00edrez","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210289","article-title":"Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women","volume":"14","author":"Dankai","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0120","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1158\/1055-9965.EPI-14-0347","article-title":"Combined CADM1\/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women","volume":"23","author":"De Strooper","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0125","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/ijc.25890","article-title":"Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women","volume":"129","author":"Overmeer","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0130","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2015.01.550","article-title":"Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1\/MAL methylation analysis on cervical scrapes","volume":"137","author":"Verhoef","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0135","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.33320","article-title":"Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: a large European multicenter study","volume":"148","author":"Bonde","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2016.02.012","article-title":"Validation of the FAM19A4\/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women","volume":"141","author":"De Strooper","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41416-021-01614-4","article-title":"Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4\/miR124-2 methylation and HPV genotyping","volume":"126","author":"Dick","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13148-020-00963-w","article-title":"Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays","volume":"12","author":"Dippmann","year":"2020","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0155","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1097\/QAD.0000000000002325","article-title":"The use of molecular markers for cervical screening of women living with HIV in South Africa","volume":"33","author":"Kremer","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0160","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/cam4.2855","article-title":"Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions","volume":"9","author":"Leeman","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0165","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/ijc.33778","article-title":"Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: a feasibility study","volume":"149","author":"Salta","year":"2021","journal-title":"Int J Cancer"},{"issue":"125","key":"10.1016\/j.ejogrb.2025.02.038_b0170","first-page":"e1","article-title":"FAM19A4\/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort","volume":"27","author":"Vink","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0175","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1093\/cid\/ciac433","article-title":"FAM19A4\/miR124-2 methylation testing and HPV16\/18 genotyping in HPV-positive women under the age of 30 years","volume":"76","author":"Vink","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jviromet.2021.114219","article-title":"Performance of a six-methylation-marker assay on self-collected cervical samples \u2013 a feasibility study","volume":"295","author":"Klischke","year":"2021","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0185","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13148-017-0419-2","article-title":"Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women","volume":"9","author":"Schmitz","year":"2017","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0190","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/ijc.34041","article-title":"Triage performance and predictive value of the human gene methylation panel among women positive on self-collected HPV test: results from a prospective cohort study","volume":"151","author":"Zhang","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ygyno.2021.02.011","article-title":"DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: real-world evidence in Taiwan","volume":"161","author":"Chang","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0200","first-page":"833","article-title":"Evaluation of PAX1 methylation triage as the primary screening method in the application of early diagnosis for cervical cancer","volume":"72","author":"Hui","year":"2019","journal-title":"C R Acad Bulg Sci"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0205","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/cam4.253","article-title":"PAX1\/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study","volume":"3","author":"Lai","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0210","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.2217\/fon-2021-1625","article-title":"Methylated ZNF582 as a triage marker for occult cervical cancer and advanced cervical intraepithelial neoplasia","volume":"18","author":"Su","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0215","doi-asserted-by":"crossref","first-page":"62274","DOI":"10.18632\/oncotarget.19459","article-title":"Utility of gene methylation analysis, cytological examination, and HPV-16\/18 genotyping in triage of high-risk human papilloma virus-positive women","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ijc.23519","article-title":"Identification of novel DNA methylation markers in cervical cancer","volume":"123","author":"Lai","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0225","article-title":"ZNF671 methylation test in cervical scrapings for cervical intraepithelial neoplasia grade 3 and cervical cancer detection","volume":"4","author":"Zhu","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0230","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1055-9965.EPI-21-1425","article-title":"Clinical performance of triage strategies for Hr-HPV-positive women; a longitudinal evaluation of cytology, p16\/K-67 dual stain cytology, and HPV16\/18 genotyping","volume":"31","author":"Stanczuk","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0235","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/1055-9965.EPI-20-0833","article-title":"Association between gene promoter methylation and cervical cancer development: global distribution and a meta-analysis","volume":"30","author":"El Aliani","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0000000000000744","article-title":"Methylation levels of CADM1, MAL, and MIR124-2 in cervical scrapes for triage of HIV-infected, high-risk HPV-positive women in Kenya","volume":"70","author":"De Vuyst","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0245","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0250","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0255","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000513517","article-title":"Preoperative evaluation of the ADNEX model for the prediction of the ovarian cancer risk of adnexal masses at Siriraj Hospital","volume":"86","author":"Poonyakanok","year":"2021","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0260","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13148-016-0196-3","article-title":"Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2\/3","volume":"8","author":"Boers","year":"2016","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2019.04.025","article-title":"Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands","volume":"125","author":"Polman","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0270","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-21-3710","article-title":"HPV and DNA methylation testing in urine for cervical intraepithelial neoplasia and cervical cancer detection","volume":"28","author":"van den Helder","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0275","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ygyno.2010.07.004","article-title":"Cost-effectiveness of using human papillomavirus 16\/18 genotype triage in cervical cancer screening","volume":"119","author":"Vijayaraghavan","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0280","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3802\/jgo.2019.30.e17","article-title":"Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology","volume":"30","author":"Termrungruanglert","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0285","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejogrb.2020.12.061","article-title":"Options for triage and implications for colposcopists within European HPV-based cervical screening programmes","volume":"258","author":"Leeson","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0290","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/cid\/ciz677","article-title":"Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia","volume":"70","author":"Louvanto","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2025.02.038_b0295","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.3390\/ijms24076479","article-title":"The role of methylation of host and\/or human papillomavirus (HPV) DNA in management of cervical intraepithelial neoplasia grade 2 (CIN2) lesions","volume":"24","author":"Dovnik","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525001071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525001071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:50:01Z","timestamp":1744177801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525001071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":59,"alternative-id":["S0301211525001071"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.02.038","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic accuracy of available methylation assays in advanced cervical intraepithelial neoplasia from high-risk HPV-positive women: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}